Study on the Use of Ointment Preparations for Transdermal Delivery of Fluvastatin
碩士 === 嘉南藥理科技大學 === 生物科技系暨研究所 === 92 === Fluvastatin is the first synthetic HMG-Co A reductase inhibitor to be approved for clinical lipid-modifying therapy. In this study, we attempt to develop a transdermal delivery system by the use of ointment dosage forms. The type of ointments include chitosan...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2004
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/29116410807784622144 |